
Shanxi Huhua Group Co., Ltd., established in 1960 and headquartered in Changzhi, China, specializes in the research, development, manufacturing, and sales of civil explosive materials and related equipment. Their comprehensive product portfolio includes a diverse array of detonators, such as advanced digital electronic, high-intensity detonating tube, seismic exploration, magnetic, industrial electric, standard detonating tube, and high-precision extended body models. The company also produces various explosive formulations, including colloidal emulsion, modified ammonium fry, powder emulsion, and expanded ammonium nitrate explosives, along with other specialized explosive devices. Beyond manufacturing, Shanxi Huhua Group facilitates import and export activities and offers professional blasting solutions. The company boasts an international presence, distributing its products to 16 countries and regions worldwide, with key export markets including Australia, South Africa, Chile, Indonesia, and Mongolia.
Shanxi Huhua Group Co., Ltd. trades as 003002.SZ on SHZ. The company is classified in Basic Materials / Chemicals - Specialty and reports in CNY.
The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Shanxi Huhua Group Co., Ltd. can be compared against peers such as Jiangsu Jiuding New Material Co., Ltd., Hubei Kailong Chemical Group Co., Ltd., Shenzhen King Explorer Science and Technology Corporation, Fujian Yuanli Active Carbon Co.,Ltd., Hunan Lead Power Dazhi Technology Incorporated Company, Anshan Hifichem Co., Ltd..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $4.30B, beta of 0.21, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
003002.SZ currently shows total debt of N/A and beta of 0.21. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.shanxihuhua.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.